This anti-inflammatory action is paralleled by a dose-dependent modulation of oxidative stress biomarkers such as GPx, CAT, and malondialdehyde (MDA), ultimately contributing to improved glucose tolerance, reduced systemic inflammation, and mitigation of high-fat diet-induced obesity in animal models [56]. The gene discussed is CAT; the disease is Obesity.